Nihon Tabako Sangyo Kabushiki Kaisha – Trademark Portfolio
Entity Type: 03
Nihon Tabako Sangyo Kabushiki Kaisha owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HIMAX, PUREUPGRADE, and TRAITEXPLORER. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 30 (Staple Foods). Headquartered in Tokyo.
2-1, Toranomon 2-chome, Minato-ku
Tokyo , JP
Showing of trademarks Trademarks
Trademark Classifications
Nihon Tabako Sangyo Kabushiki Kaisha's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Nihon Tabako Sangyo Kabushiki Kaisha have?
Nihon Tabako Sangyo Kabushiki Kaisha has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Nihon Tabako Sangyo Kabushiki Kaisha file in?
Nihon Tabako Sangyo Kabushiki Kaisha files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 30 (Staple Foods), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Nihon Tabako Sangyo Kabushiki Kaisha's most well-known trademarks?
Nihon Tabako Sangyo Kabushiki Kaisha's registered trademark portfolio includes well-known marks such as HIMAX, PUREUPGRADE, and TRAITEXPLORER. These are among 3 currently registered trademarks in the portfolio.
What is Nihon Tabako Sangyo Kabushiki Kaisha's trademark registration success rate?
Nihon Tabako Sangyo Kabushiki Kaisha has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.